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Depressive disorders often co-occur with personality disorders. The extent to which depressive disorders
inﬂuence treatment outcome in personality disorders remains unclear. The aim of this study was to
determine the impact of co-morbid depression on recovery from personality disorders and improve-
ments in psychosocial functioning. This study drew data from a randomized-controlled trial in which
patients (N ¼ 320) with cluster-c (92%), paranoid, histrionic and/or narcissistic personality disorders
received schema-therapy, treatment-as-usual, or clariﬁcation-oriented psychotherapy. Recovery from
personality disorders at three-year follow-up and improvements in psychosocial functioning over a
course of three years was predicted by the diagnostic status of depressive disorders at baseline using
mixed model regression analyses. Based on the number of axis-I and axis-II disorders, personality dis-
order severity and global symptomatic distress and functioning a baseline severity index was computed
and included in subsequent analyses to test the speciﬁcity of baseline depression in predicting outcomes.
Patients with co-occurring depression reported higher baseline severity compared to patients without
co-occurring depression. Depression at baseline was associated with lower recovery rates at three-year
follow-up (p ¼ 0.01) but this effect disappeared after controlling for baseline severity. Patients with
depression at baseline reported higher psychosocial impairments throughout treatment (p < 0.001).
Depression at baseline did not moderate treatment effects except for one psychosocial outcome measure.
In conclusion, depression is associated with lower recovery rates from personality disorders but this
effect disappears when general severity is taken into account. Patients with primarily cluster-c per-
sonality disorders and co-occurring depression might beneﬁt from additional depression treatment in
terms of improved psychosocial functioning.
© 2014 Published by Elsevier Ltd.Introduction
Personality disorders and depressive disorders often co-occur.
Results from the Collaborative Longitudinal Personality Disorders
Study (CLPS; Gunderson et al., 2000) suggest that about 60% of
patients with a personality disorder also have a current depressive
disorder (Skodol et al., 1999). This high comorbidity can haveaastricht, The Netherlands.
.nl (F. Renner).important treatment implications. Depressive disorders among
patients with personality disorders might interfere with recovery
from personality disorders and psychosocial adjustments during
treatment. Most previous research on the association between
depressive and personality disorders has focused on the impact of
personality disorders on recovery of depression (e.g. Newton-
Howes, Tyrer, & Johnson, 2006; Newton-Howes et al., 2014)
rather than on the impact of comorbid depression on recovery of
personality disorders.
Three previous studies drew data from a naturalistic cohort
study, the CLPS (Gunderson et al., 2000), to study the relation be-
tween depression and personality disorder outcomes. Shea et al.
Table 1
Demographic and clinical characteristics of patients with co-occurring depression
and patients without co-occurring depression at baseline.
Depression
(n ¼ 141)
No depression
(n ¼ 179)
t-test
(p-value)
c2
(p-value)
Gender, n (%) e 0.650
Female 82 (58.2) 99 (55.3)
Male 59 (41.8%) 80 (44.7)
Age (years), M (SD) 37.62 (9.36) 38.27 (9.82) 0.545 e
Personality disorder diagnosis, n (%)
Avoidant 99 (70.2) 107 (59.8) e 0.06
Obsessive-compulsive 51 (36.2) 71 (39.7) e 0.523
Depressive 52 (36.9) 41 (22.9) e 0.006
Dependent 25 (17.7) 25 (14) e 0.357
Paranoid 6 (4.3) 4 (2.2) e 0.302
Narcissistic 8 (5.7) 9 (5) e 0.798
Passive-aggressive 6 (4.3) 4 (2.2) e 0.302
Histrionic 0 2 (1.1) e 0.208
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ces of remission from borderline personality disorder at two-year
follow-up (Shea et al., 2004). Hellerstein et al. (2010) found that
personality disorder patients with comorbid dysthymic disorder
had a higher chance to still meet criteria of a personality disorder
and had worse psychosocial functioning at a two-year follow up
assessment. Finally, Gunderson et al. (2004) found no evidence that
the presence of major depressive disorder was associated with
remission of borderline personality disorder at three-year follow-
up. Another prospective longitudinal study found that borderline
personality disorder patients who did not meet criteria for a mood
disorder had higher chances to reach remission during one of the
follow-up assessments at 2, 4, or 6-years (Zanarini, Frankenburg,
Hennen, Reich, & Silk, 2004).
In these naturalistic cohort studies it remains unclear how
depression is related to treatment outcome for personality disor-
ders as the potential inﬂuence of depression on treatment alloca-
tion is not controlled for. The types and adequacy of received
treatments remains unclear and patient cohort studies are poten-
tially confounded by indication: personality disorder patients with
comorbid depression participating in a cohort study might receive
qualitatively and quantitatively different treatments than patients
without comorbid depression. The effects of depression on
outcome in personality disorders should therefore be studied in
randomized controlled trials (RCT) where patients are randomized
to treatment conditions regardless of depression comorbidity.
Therefore, the aim of this study was to determine the impact of
comorbid depression on recovery from personality disorders and
improvements in psychosocial functioning in patients with per-
sonality disorders participating in an RCT (Bamelis, Evers, & Arntz,
2012). To the best of our knowledge, the current study is the ﬁrst to
determine the impact of comorbid depression on outcome in the
treatment of personality disorders in an RCT. We hypothesized that
the presence of a diagnosis of a current DSM-IV depressive disorder
at baseline would predict lower recovery levels and less improve-
ment in psychosocial functioning at 3-year follow-up.
Methods
The present study is based on data from a multi-centre ran-
domized controlled trial on the (cost-)effectiveness of schema
therapy for personality disorders. A more detailed description of
the design, methods, and interventions of this study is available
elsewhere (Bamelis et al., 2012). In this study 323 patients with a
primary diagnosis of a DSM-IV cluster-c (92%), histrionic, narcis-
sistic or paranoid personality disorder were randomized to a 50
session protocol of schema therapy (n ¼ 147; Arntz, 2012),
treatment-as-usual (n ¼ 135), or clariﬁcation-oriented psycho-
therapy (n ¼ 41; Sachse, 2001). The reason for the exclusion of
other personality disorders was that they were assumed to require
lengthier and highly specialized treatment protocols. Inclusion
criteria for participation in the study were a diagnosis of at least
one DSM-IV personality disorder, as assessed with the Structured
Clinical interview for DSM-IV Axis II personality disorders (SCID-II)
(First, Spitzer, Gibbon, & Williams, 1994); age between 18 and 65
years. Patients were excluded if they met full or sub-threshold
criteria of antisocial, schizotypal, schizoid or borderline personal-
ity disorder; had a present or lifetime diagnosis of psychosis or
bipolar disorder; had an IQ below 80; had acute suicide risk or
reported substance abuse that required detoxiﬁcation. Of the 323
patients who were randomized, 2 moved away during the
randomization period and one withdrew consent so that the ﬁnal
analyses sample is based on 320 patients. Table 1 provides an
overview of basic demographic characteristics of the sample and
the speciﬁc personality disorder diagnoses.Measures
The primary outcome measure in the current study was recov-
ery from personality disorders, as assessed by blinded independent
interviewers with the SCID-II interview at three-year follow-up.
Recovery was deﬁned as not meeting diagnostic criteria of any
personality disorder. The inter-rater reliability for the SCID-II in the
current study was good (Intraclass correlation coefﬁcient ¼ 0.84;
based on 42 double-rated interviews; Bamelis, Evers, Spinhoven, &
Arntz, 2014). Reliability data for the SCID-I mood disorder di-
agnoses are not available from the present study, but raters from
our research group who received the same training attained fair to
excellent inter-rater reliability for major depressive disorder (kappa
0.66) and dysthymia (kappa 0.81) in a different sample (Lobbestael,
Leurgans, & Arntz, 2011). If SCID-II assessments were missing
(35.9% missing at follow-up) the personality disorder diagnoses
from the last available Assessment of DSM-IV Personality Disorders
Questionnaire (ADP-IV; Schotte & Doncker, 1996) were used
instead. The ADP-IV is a self-report questionnaire that was assessed
at every intermediate and follow-up assessment. Participants
indicated along a 7-point Likert scalewhether a DSM-IV personality
disorder criteria applies to them (1¼ not at all; 7¼ completely) and
the degree of distress they experience from that criteria. These
assessments form the ADP-IV traits and ADP-IV distress scales.
Adequate psychometric properties have been reported for the ADP-
IV (Schotte, De Doncker, Vankerckhoven, Vertommen, & Cosyns,
1998; Schotte et al., 2004).
Assessor based secondary outcomes were global functioning as
assessed by the Global Assessment of Functioning Scale (GAF;
American Psychiatric Association, 2005) and psychosocial func-
tioning as assessed by the Social and Occupational Functioning
Scale (SOFAS; American Psychiatric Association, 2005). Indepen-
dent assessors rated participants every 6 months on the scales after
a semi-structured interview designed to elicit information neces-
sary for the rating. Self-reported psychosocial functioning was
assessed using the Work and Social Adjustments Scale (WSAS;
Mundt, Marks, Shear, & Greist, 2002).
Axis-I mood disorders at baseline were assessed by research
assistants using the Structured Clinical Interview for DSM-IV Axis-I
disorders (First, Spitzer, Gibbon,&Williams, 1997). A more detailed
description of the instruments used in the study and their psy-
chometric properties is available elsewhere (Bamelis et al., 2012).
Interventions
Schema therapy (ST) is an integrative psychotherapy combining
experiential, cognitive-behavioural, psychodynamic and interper-
sonal techniques (Young, Klosko, &Weishaar, 2003). In the current
Table 2
Co-occurrence of depressive disorders across treatment conditions.
ST
(n ¼ 145)
COP
(n ¼ 41)
TAU
(n ¼ 134)
Overall
(n ¼ 320)
c2
(p-value)
Single episode 10 (6.9%) 2 (4.9%) 8 (6%) 20 (6.3%) 0.50
Recurrent 33 (22.8%) 13 (31.7%) 34 (25.4%) 80 (25%) 0.88
Dysthymia 25 (17.2%) 12 (29.3%) 23 (17.2%) 60 (18.9%) 0.18
Any depressive
disorder
60 (41.4%) 23 (56.1%) 58 (43.3%) 141 (44.1%) 0.24
Note: ST ¼ Schema Therapy; COP ¼ Clariﬁcation-Oriented Psychotherapy;
TAU ¼ treatment-as-usual.
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sessions ST in year 1 and 10 booster sessions in year 2 was imple-
mented (Arntz, 2012). Clariﬁcation-Oriented Psychotherapy (COP)
is based on principles from client centred therapy and focuses on
interpersonal problems (Sachse, 2001). In the current study weekly
individual COP sessions were provided in an open ended fashion.
Both ST and COP therapists were trained at the start of the study
during a 4-day training, received supervision once a year and
weekly peer-supervision. ST therapists were trained in two cohorts,
one receiving mainly lectures and video demonstrations and one
participating in active role-plays and receiving individual feedback
(Bamelis et al., 2012). Treatment-as-usual (TAU) consisted of
whatever treatment the local intake staff indicated (except for STor
COP), following the Dutch clinical guidelines for treating patients
with personality disorders. All TAU was primarily psychological
treatment (21% CBT or EMDR, 32% supportive therapy, 42% insight
oriented psychotherapy). Therapists in the TAU condition did not
follow a standardized study protocol and did not receive training or
supervision for the study but had standard local peer-supervision.
The median number of sessions in TAU was 22.
Statistical analyses
All analyses were based on the intention-to-treat principle by
including all available data in the analyses. ST therapists trained in
the second, more interactive, cohort had better effects than ST
therapists trained in the ﬁrst cohort (Bamelis et al., 2014). We
therefore included therapist training cohort effects in all analyses of
primary and secondary outcomes, represented by a centred co-
variate (0.5 for ﬁrst, 0.5 for second cohort; 0 for COP (Bamelis
et al., 2014)). Depression at baseline was operationalized as the
presence (coded 1) or absence (coded 0) of any depressive disorder
at baseline (major depressive disorder single episode, recurrent
major depressive disorder and/or dysthymia). In all prediction
models the effect of baseline depression (and baseline
depression  time interactions for continuous outcomes) was of
primary interest. The depression  condition (for continuous out-
comes the time  depression  condition) interaction was of sec-
ondary interest, testing moderation of treatment by depression.
For dichotomous outcomes we used mixed logistic regression
analyses with participants nested within clinical sites. The depen-
dent variable in this analysis was recovery of personality disorders
at three-year follow-up. Fixed effects included depressive disorder
diagnostic status at pre-treatment, treatment condition, cohort as
well as the depression  treatment condition and
cohort  treatment condition interactions. Non-signiﬁcant inter-
action terms were removed from the model in order to estimate
main effects. Random effects included random intercepts for the 12
different clinical sites. We computed a baseline severity-index
(internal consistency 0.76) based on standardized scores of the
number of axis-I disorders (except for current depressive disor-
ders), the number of axis-II disorders, ADP-IV scores, Symptom
Checklist-90 total score, Global Assessment of Functioning score
and the Social and Occupational Functioning Assessment Score. The
severity index is the average of these standardized variables and
has a mean of 0. Scores above 0 represent higher baseline severity
and scores below 0 represent lower baseline severity. Baseline
severity was included as ﬁxed effect in themixed logistic regression
analyses predicting recovery by depressive symptom severity. We
computed a separate baseline severity-index for the models pre-
dicting change in psychosocial functioning, excluding the Global
Assessment of Functioning score and the Social and Occupational
Functioning Assessment Score.
For continuous outcomes we used mixed linear regression an-
alyses with repeated assessments nested within participantsnested within clinical sites. For repeated measures an unstructured
covariance structure was speciﬁed. Fixed effects included a general
time variable, depressive disorder diagnostic status at baseline,
dummy coded (0,1) variables for treatment conditions with
treatment-as-usual as reference condition, cohort, the two-way
time  treatment condition, time  cohort, and
time  depression interactions. Moderation of treatment effects by
depression at baseline was modelled by including the time  ST
(resp. COP) depression three-way interactions. Moderation of the
superior effects of the second ST cohort by depression at baseline
was modelled by including the time  ST  cohort  depression
four-way interaction along with the respective lower-order in-
teractions. Random intercepts and random slopes were speciﬁed
for clinical sites. For all continuous outcomes we calculated the
effect-size r, based on the multilevel estimates, using the following
formula: r ¼ SQRT(t2/(t2 þ df)). A more detailed description of the
analytical approach for primary and secondary outcomes in the
current study as well as a number of sensitivity analyses is provided
elsewhere (Bamelis et al., 2014).Results
Comorbid depression at baseline
Table 2 provides an overview of the distribution of current
depressive disorders at baseline across the three treatment condi-
tions. Of the overall sample of 323 patients with a primary per-
sonality disorder 44.1% (n ¼ 141) also met the criteria of a current
depressive disorder at baseline. Patients who met DSM-IV criteria
for a depressive disorder not otherwise speciﬁed (n ¼ 2) were not
included in the comorbid depression at baseline group. There were
no statistical signiﬁcant differences in the distribution of depressive
disorders at baseline across the three treatment conditions (Chi-
square tests; all p-values >0.05).Baseline severity in patients with and without co-occurring
depression
To determine whether patients with depression at baseline
differed from patients without depression at baseline on the clin-
ical baseline variables from which the severity index was
computed, we conducted a number of independent sample t-tests.
The number of current axis-I and current axis-II disorders were
non-normally distributed and therefore compared using a non-
parametric test (ManneWhitney U Test). Patients with co-
occurring depression at baseline had a higher number of axis-I
disorders and axis-II disorders, scored higher on ADP-IV trait and
distress scales, had higher SCL-90 total scores and lower func-
tioning on the GAF and SOFAS at baseline (all p-values <0.01;
Table 3). The correlation between depression at baseline and gen-
eral severity at baseline was r ¼ 0.31, p < 0.001.
Table 4
Results of mixed logistic regression analyses predicting recovery by baseline
depression before and after controlling for baseline severity.
Estimate t df p 95% CI (B)
Recovery not controlled for baseline severity
Baseline depression 0.63 2.57 314 0.01 1.47; 0.11
Recovery controlled for baseline severity
Baseline depression 0.15 0.55 313 0.58 0.38; 0.68
Baseline severity 1.13 4.75 313 <0.001 1.60; 0.66
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First we conducted a mixed logistic regression analyses to pre-
dict recovery from personality disorder by current depression at
baseline. The interaction between current depression and treat-
ment condition was not signiﬁcant (p ¼ 0.51), indicating that
depression at baseline did not moderate the difference between
treatment conditions on outcome. After removing the non-
signiﬁcant interaction term from the model there was a signiﬁ-
cant main effect of current depression on recovery (p ¼ 0.01;
Table 4). The estimated proportion of recovery for patients without
a diagnosis of current depression at baseline was 0.70 whereas the
estimated proportion of recovery for patients with a current
depression diagnosis at baseline was 0.56.
Given that the two groups also differed on a number of impor-
tant clinical variables (Table 3) we added general baseline severity
to the model to determine whether the effects of baseline
depression on recovery can better be accounted for by overall
severity. After adding baseline severity to the model the effect of
baseline depressionwas not signiﬁcant anymore (p¼ 0.58; Table 4).
Baseline severity was a signiﬁcant predictor of recovery (p < 0.001),
indicating that patients with higher baseline severity had lower
recovery rates compared to patients with low baseline severity.
Subgroup analyses
The diagnostic categories for the subgroup analyses reﬂect
patients fulﬁlling the criteria for a given personality disorder
which is not necessarily the primary diagnosis of that patient.
The number of patients fulﬁlling the criteria for an avoidant,
obsessive-compulsive, depressive or dependent personality dis-
order was considered sufﬁcient (i.e. n > 20) to allow for addi-
tional subgroup analyses within these diagnostic categories.
Within each of these PDs the interaction between current
depression and treatment condition was not signiﬁcant and
neither was the main effect of depression after deleting the ns
interaction (all p-values >0.05). Within the subgroup of patients
with any cluster-c PD current depression at baseline was signif-
icant (p ¼ 0.018), after deleting the ns interaction term. As in the
main analyses the effect disappeared after controlling for base-
line severity and baseline severity was a signiﬁcant predictor
(p < 0.001). Together, this shows that the pattern of ﬁndings
regarding the relation between depression at baseline and re-
covery does not differ for patients with avoidant, obsessive-
compulsive, depressive or dependent personality disorder. The
fact that the relation between depression at baseline and re-
covery was not-signiﬁcant within the different diagnostic cate-
gories probably reﬂects a power problem.Table 3
Means and standard deviations of baseline severity indicators across the two groups.
Depression
(n ¼ 141)
Mean (SD)
No depression
(n ¼ 179)
Mean (SD)
t(df) U p
# Axis-I disordersa 1.31 (1.14) 0.96 (1.11) e 15.16 <0.01
# Axis-II disorders 1.79 (0.83) 1.53 (0.73) e 14.85 <0.01
ADP4 traits 312.00 (66.03) 283.32 (69.89) 3.73 (318) e <0.001
ADP4 distress 153.56 (29.40) 144.75 (28.47) 2.71 (318) e <0.01
SCL-90 228.40 (57.39) 189.40 (49.52) 6.52 (318) e <0.001
GAF 54.4 (7.91) 57.46 (9.28) 3.12 (318) e <0.01
SOFAS 54.01 (9.00) 57.43 (10.20) 3.14 (318) e <0.01
Severity index 0.21 (0.57) 0.16 (0.58) 5.71 (138) e <0.001
Note: GAF ¼ Global Assessment of Functioning; SOFAS ¼ Social and Occupational
Functioning Scale.
a Excluding current depressive disorders.Effect of current depression on changes in psychosocial functioning
We used mixed regression analyses to determine the effects of
current depression on improvements in psychosocial functioning
over the course of treatment. The results of these analyses are
summarized in Table 5. First we tested a model including a
time  cohort  ST  depression four-way interaction to test
whether baseline depression moderated the superior effects of the
second schema-therapist cohort on psychosocial adjustments that
was found in the main effectiveness analyses (Bamelis et al., 2014).
For all three psychosocial functioning measures the four-way
interaction was not signiﬁcant (GAF: p ¼ 0.95; SOFAS: p ¼ 0.84;
WSAS: p ¼ 0.24) and therefore removed from the model.
After removal, the time  depression  ST and the
time  depression  COP three-way interactions were not signiﬁ-
cant (all p-values >0.05) and therefore removed from the model,
starting with the least signiﬁcant.
After removing the non-signiﬁcant time  depression  COP
interaction in the model predicting change in GAF scores, a sig-
niﬁcant time  depression  ST interaction emerged, F(1,
234.82) ¼ 5.20, p ¼ 0.02, r ¼ 0.15 (Table 5). Closer inspection of the
meaning of this interaction revealed that patients without
depression at baseline in the schema therapy condition had more
improvements in overall functioning than those in TAU, whereas
there was no difference in those with comorbid depression. The
time  depression interaction was not signiﬁcant, but depression
predicted lower GAF-scores throughout 3 years (Fig. 1A).
Following these analyses, we added baseline severity as pre-
dictor to test whether the effects of baseline depression on global
functioning can better be explained by overall symptomatic
severity (Table 5). After adding baseline severity to the model, the
interaction between time  depression  ST remained signiﬁcant,
F(1, 237.22) ¼ 4.96, p ¼ 0.03, r ¼ 0.10. Baseline severity was a sig-
niﬁcant predictor of global functioning throughout treatment, F(1,
287.12) ¼ 39.39, p < 0.001, r ¼ 0.14, suggesting that patients with
higher severity at baseline reported overall lower levels of global
functioning throughout treatment (Fig. 1B). The main effect of
depression remained signiﬁcant, F(1, 321.12) ¼ 5.75, p ¼ 0.02,
r ¼ 0.13. The interaction between time and baseline severity was
not signiﬁcant, F(1, 232.40)¼ 0.47, p¼ 0.49, r¼ 0.04, indicating that
changes in global functioning throughout treatment did not differ
for patients with low versus high levels of baseline severity. Finally,
we added the time  baseline severity  ST three-way interaction,
along with the respective two-way interactions. The
time  baseline severity  ST three-way interaction was not sig-
niﬁcant, F(1, 227.64) ¼ 2.03, p ¼ 0.16, r ¼ 0.09. After adding this
interaction the time baseline depression ST interaction became
non-signiﬁcant, F(1, 232.81) ¼ 3.25, p ¼ 0.07, r ¼ 0.12.
In the model predicting change in SOFAS scores, the
time  depression interaction was not signiﬁcant, F(1,
228.55) ¼ 0.04, p ¼ 0.85, r ¼ 0.01 and was therefore removed from
the model. After removal a signiﬁcant main effect of depression
emerged, F(1, 293.24) ¼ 11.31, p ¼ 0.001, r ¼ 0.19, indicating that
patients with current depression at baseline reported lower SOFAS
levels throughout treatment (Fig. 1A).
Table 5
Results of mixed regression analyses predicting (change in) psychosocial functioning over time by depressive disorders at baseline.
Estimate t df p 95% CI (B) r
GAF: not controlled for baseline severity
Time 1.82 4.25 38.71 <0.001 0.95; 2.69 0.56
Depression 4.54 3.33 319.86 <0.01 7.21; 1.86 0.18
Time  Depression 0.75 1.68 238.00 0.09 1.29; 1.64 0.11
Time  Depression  ST 1.48 2.28 234.82 0.02 2.75; 0.20 0.15
GAF: controlled for baseline severity
Time 1.85 4.33 38.54 <0.001 0.99; 2.72 0.57
Depression 3.15 2.40 321.12 0.02 5.74; 0.57 0.13
Baseline severity 3.67 6.28 287.12 <0.001 4.82; 2.52 0.35
Time  Depression 0.73 1.63 240.70 0.11 0.15; 1.60 0.10
Time  Depression  ST 1.44 2.23 237.22 0.03 2.71; 0.17 0.14
SOFAS: not controlled for baseline severity
Including time  depression interaction
Time 1.95 4.58 29.78 <0.001 1.08; 2.81 0.64
Depression 3.15 3.23 197.15 <0.001 5.06; 1.23 0.22
Time  Depression 0.06 0.19 228.55 0.85 0.56; 0.69 0.01
SOFAS: not controlled for baseline severity
Without ns. time  depression interaction
Time 1.97 4.83 25.96 <0.001 1.13; 2.81 0.69
Depression 3.08 3.36 293.24 <0.01 4.89; 1.28 0.19
SOFAS: controlled for baseline severity
Including time  depression interaction
Time 1.96 4.63 29.73 <0.001 1.09; 2.83 0.65
Depression 1.75 1.80 301.54 0.07 3.67; 0.16 0.10
Baseline severity 3.53 5.44 291.37 <0.001 4.81; 2.25 0.30
Time  Depression 0.06 0.18 230.55 0.85 0.57; 0.68 0.01
SOFAS: controlled for baseline severity
Without ns. time  depression interaction
Time 1.98 4.88 25.91 <0.001 1.15; 2.82 0.69
Depression 1.69 1.85 290.08 0.065 3.59; 0.11 0.11
Baseline severity 3.53 5.44 291.37 <0.001 4.81; 2.56 0.30
WSAS: not controlled for baseline severity
Including time  depression interaction
Time 1.07 3.71 33.77 <0.01 1.65; 0.48 0.54
Depression 4.85 5.96 307.86 <0.001 3.25; 6.45 0.32
Time  Depression 0.32 1.43 259.74 0.15 0.77; 0.12 0.09
WSAS: not controlled for baseline severity
Without ns. time  depression interaction
Time 1.20 4.47 30.41 <0.001 1.76; 0.65 0.63
Depression 4.48 5.81 306.08 <0.001 2.96; 6.00 0.32
WSAS: controlled for baseline severity
Including time  depression interaction
Time 1.09 3.80 33.94 <0.01 1.67; 0.51 0.55
Depression 2.74 3.72 311.92 <0.001 1.29; 4.19 0.21
Baseline severity 5.16 10.38 307.60 <0.001 4.18; 6.13 0.51
Time  Depression 0.30 1.32 259.21 0.19 0.74; 0.15 0.08
WSAS: controlled for baseline severity
Without ns. time  depression interaction
Time 1.21 4.52 30.44 <0.001 1.77; 0.67 0.63
Depression 2.45 3.49 305.60 <0.01 1.07; 3.83 0.20
Baseline severity 5.16 10.40 307.50 <0.001 4.18; 6.14 0.51
Note: GAF¼ Global Assessment of Functioning; SOFAS¼ Social and Occupational Functioning Scale; WSAS¼Work and Social Adjustment Scale. Higher scores on the GAF and
SOFAS indicate better functioning. Higher scores on theWSAS indicate worse functioning. Table showsmodel including higher order two-way interaction terms and in case of
non-signiﬁcant interactions models only including main effects of depression. All models are controlled for cohort.
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social and occupational functioning throughout treatment can
better be accounted for by baseline severity we added baseline
severity (Table 5). After controlling for baseline severity in the
model without the non-signiﬁcant time  depression interaction,
the main effect of depression at baseline became non-signiﬁcant,
F(1, 290.08) ¼ 3.43, p ¼ 0.065, r ¼ 0.11. There was a signiﬁcant
main effect of baseline severity, F(1, 291.37) ¼ 29.60, p < 0.001,
r ¼ 0.30, indicating that patients with higher baseline severity re-
ported more impairments in social occupational functioning
throughout treatment (Fig. 1B). The interaction between time and
baseline severity was not signiﬁcant, F(1, 226.88) ¼ 0.11, p ¼ 0.74,
r ¼ 0.02 indicating that changes in social and occupational func-
tioning did not differ for patients with low and high levels of
baseline severity.In the model predicting change in WSAS scores, the
time  depression interaction was not signiﬁcant, F(1,
259.74) ¼ 2.05, p ¼ 0.15, r ¼ 0.09 and was therefore removed from
the model. After removal there was a signiﬁcant main effect of
depression, F(1, 306.08) ¼ 33.72, p < 0.001, r ¼ 0.32, indicating that
patients with current depression at baseline reported higher WSAS
levels throughout treatment (Fig. 1A). To test whether the effect of
depression on self-reported work and social functioning can better
be accounted for by general severity, we also added the baseline
severity index as predictor (Table 5). After adding baseline severity
to the model without the non-signiﬁcant time  depression
interaction, the main effect of depression at baseline remained
signiﬁcant, F(1, 305.60) ¼ 12.17, p < 0.01, r ¼ 0.20. Moreover, there
was a signiﬁcant main effect of baseline severity onwork and social
adjustments, F(1, 307.50) ¼ 108.11, p < 0.001, r ¼ 0.51 (Fig. 1B). The
Fig. 1. Change in global functioning, social and occupational functioning and work and social adjustment across 32 months by depression at baseline (part A) and by low and high
severity (part B). Note: GAF ¼ Global Assessment of Functioning; SOFAS ¼ Social and Occupational Functioning Assessment Scale; WSAS ¼ Work and Social Adjustment Scale.
Higher scores on the GAF and SOFAS indicated better functioning. Higher scores on the WSAS indicate worse functioning.
F. Renner et al. / Behaviour Research and Therapy 63 (2014) 55e6260interaction between time and baseline severity was not signiﬁcant,
F(1, 252.34) ¼ 1.38, p ¼ 0.24, r ¼ 0.07, indicating that changes in
work and social adjustments did not differ for patients with low
and high levels of symptom severity at baseline.
Discussion
The aim of this study was to determine the impact of comorbid
depression at baseline on treatment outcome for patients with
primarily cluster-c (92%) personality disorders. In the current study
about 44% of all patients also met criteria for comorbid depression
at baseline. These prevalence rates are slightly lower than those
previously reported in a large naturalistic cohort study (Skodol
et al., 1999). In the current study, patients with comorbid depres-
sion at baseline experienced less recovery from personality disor-
ders at three-year follow-up compared to patients without
comorbid depression at baseline and this effect did not differ be-
tween treatment conditions. After controlling for general severity
at baseline, the impact of comorbid depression at baseline on re-
covery was not statistically signiﬁcant anymore.
Our ﬁndings suggest that the chances of recovery following
treatment for personality disorders for patients with comorbid
depression do not differ from those of personality disorder patients
without comorbid depression, after controlling for overall severity.
Although one might argue that general severity is just another in-
dex for depressive symptom severity, it should be noted, that the
relation between general severity and depression at baseline was
not very large (r ¼ 0.31), suggesting that these two variables
measured different, though overlapping, constructs. Moreover, we
found an adequate internal consistency of the general severity in-
dex suggesting that the different variables on which the severity
index was based could be meaningfully combined. Another po-
tential issue that could complicate the interpretation of the results
from the current study has to do with the potential complexity of
diagnosing depressive disorders in patients with personality dis-
orders. However, given that in the current study diagnostic in-
terviews were conducted by trained clinicians it is unlikely that the
depressive state coloured personality disorder assessments or vice
versa. During the SCID-II interview, the interviewer must carefullydetermine whether personality disorder symptoms are also pre-
sent during periods of normal mood.
Overall, these ﬁndings differ from those of a previous natural-
istic cohort study showing that personality disorder patients with
co-morbid dysthymic disorder had lower recovery rates at two-
years follow-up compared to patients without comorbid dysthy-
mic disorder (Hellerstein et al., 2010). However, the Hellerstein
et al. study did not test whether severity was a stronger predictor,
overruling the effects of depression. Our results suggest that not
depression per se but rather general severity is a negative predic-
tive factor in the treatment of personality disorders. Higher severity
probably means that a larger improvement has to take place to
cross the threshold for recovery from personality disorder diag-
nosise note that the severity index included number of personality
disorders and self-reported personality disorder-pathology. Future
studies predicting outcome of personality disorders with depres-
sion should take into account general severity.
In the current study patients with primarily cluster-c person-
ality disorders were randomized to treatment protocols, whereas
patients in previous cohort studies received treatment in uncon-
trolled, naturalistic settings. It has been argued that the relation
between personality pathology and treatment outcome in depres-
sion might be an artefact of the research design, with the less
controlled studies generally supporting such a link whereas
controlled studies generally do not support the notion that per-
sonality disorders have a negative impact on treatment outcome in
depression (Mulder, 2002). The same might hold for the impact of
depression on outcome in personality disorders. Personality dis-
order patients with comorbid depression in naturalistic settings
might be treated for depressive symptoms instead of the underly-
ing personality pathology and hence report lower remission rates
from personality disorders compared to personality disorder pa-
tients without comorbid depression. In contrast, patients in the
current study were randomized to treatment for personality dis-
orders regardless of their depressive disorder status at baseline. It
should be noted, however, that it cannot be ruled out completely
that patients with co-occurring depression in the current study
were treated differently than patients without co-occurring
depression. It is possible that the speciﬁc content of the therapy
F. Renner et al. / Behaviour Research and Therapy 63 (2014) 55e62 61sessions and therapeutic style differed between patients with
depression compared to patients without co-occurring depression.
In the current study personality disorder patients with co-
occurring depression differed on a number of important clinical
variables (number of axis-I and axis-II disorders, personality dis-
order traits and distress, general severity, and psychosocial and
general functioning) from personality disorder patients without co-
occurring depression. The overall severity was a better predictor of
recovery than the presence of depressive disorders. Results of
previous studies might have differed if these studies had taken
these clinically important variables into account when predicting
recovery from personality disorders by depression.
We also determined the impact of comorbid depression on
psychosocial functioning during three-years and found that pa-
tients with comorbid depression at baseline reported worse
psychosocial functioning throughout this period, compared to
patients who had no comorbid depression at baseline. However,
comorbid depression had no impact on the improvements in
psychosocial functioning over the course of treatment. These
ﬁndings suggest that depression among patients with personal-
ity disorders does not interfere with improvements in psycho-
social functioning during the course of treatment. Yet, the initial
worse psychosocial functioning in personality disorder patients
with comorbid depression does not catch up with the post
treatment functioning of patients without comorbid depression
in the treatment of personality disorders, leaving personality
disorder patients with depression at an improved but still higher
level of psychosocial impairments at post-treatment. After con-
trolling for baseline-severity the effects of depression on psy-
chosocial functioning remained largely stable, suggesting that
these effects were not better accounted for by general symptom
severity.
In the models predicting change in GAF scores over time there
was a statistically signiﬁcant time  depression  schema therapy
interaction, indicating that patients without depression at baseline
who were randomized to schema therapy (ST) had more im-
provements on the GAF compared to patients without depression
at baseline who were randomized to TAU. No differences between
ST and TAU for improvements in global functioning emerged for
those with co-occurring depression. It should be noted, that the
effect size of this interaction was small (r ¼ 0.15) and this interac-
tion was not-signiﬁcant for the other psychosocial functioning
measures. It therefore remains unclear how robust this ﬁnding is.
The degree to which personality disorder patients with co-
occurring depression or patients with primary depression beneﬁt
from STon global functioning ratings is an issue for future research.
Limitations
First, the current study focused on patients with predominantly
cluster-c personality disorders (92%) and it therefore remains un-
clear how our results would generalize to patients with other
personality disorders. For example, depression is also known to
frequently co-occur with borderline personality disorder and it is
unclear if co-occurring depression has a negative impact on treat-
ment outcomes of borderline personality disorder. Second, we
determined the impact of categorical depression diagnoses but did
not take dimensional measures of depression into account. One
previous study on the impact of personality disorders on treatment
outcome in depression suggests that dimensional but not cate-
gorical assessments of personality pathology predicts treatment
outcome for depression (Levenson, Wallace, Fournier, Rucci, &
Frank, 2012). The same might hold for the prediction of recovery
from personality disorders by dimensional rather than categorical
measures of depressive symptoms.Clinical implications
Clinically, our ﬁndings suggest that the presence of a current
depressive disorder does not worsen treatment outcome in pa-
tients with primarily cluster-c personality disorders. The chances of
recovery for patients with depression upon entering treatment for
personality disorders do not differ from those without depression
after controlling for general severity. This ﬁnding suggests that for
personality disorder patients with comorbid depression it is not
necessary to treat depressive disorders before treating the per-
sonality disorder in order to reach similar remission rates as in
personality disorder patients without depression. Our results sug-
gest that the chances for recovery from personality disorders in
treatment are worse for patients with greater overall severity upon
entering treatment. Finally, personality disorder patients with co-
morbid depression might start and end treatment with relatively
more impairment in psychosocial functioning than personality
disorder patients without depression, although they proﬁt from
treatment. These patients might beneﬁt from additional treatment
of depressive symptoms in terms of improvements in psychosocial
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